Urology News: Breaking Urology News, Comments and Articles. - Page: 2

Multiple System Atrophy (MSA) Research Grant Program Announced

The Multiple System Atrophy Coalition launches its new MSA Research Grant program, including the creation of a world-class Scientific Advisory Board and Advocate Research Committee to review research proposals and recommend grants. Raleigh, NC (PRWEB) May 20, 2013 The Multiple System Atrophy Coalition (formerly the SDS/MSA Support Group) announced today the launch of its new Multiple System Atrop...

Actavis to acquire Warner Chilcott for $8.5bn

Generic drugmaker Actavis has entered into a definitive agreement to acquire the international pharma company Warner Chilcott plc for US $8.5 billion. If successfully completed, this transaction will create the third-largest US global specialty pharm...

Reducing Lower Back Pain and Payments with Allen’s Device is in Line with Latest Recommendations for Back Pain Management, Highlights Fine Treatment

“Rather than teaching young doctors, ‘don't just stand there … do something’, we need to teach them, ‘don't just do something, stand there and listen’," says Michael Wilkes, M.D., who is a professor of medicine at the University of California, Davis. This is in line with the Fine Treatment recommendation to use natural Dr. Allen’s devices costing only $150, to relieve pa...

LUNGevity Foundation Hosts Second Annual Ping Pong Tournament

NEW YORK, May 20, 2013 /PRNewswire-USNewswire/ -- For the second year, LUNGevity Foundation, the nation's largest lung cancer-focused nonprofit, will host a unique evening of ping pong to raise money for lung cancer at SPiN Galactic in New York City on June 5, 2013. The fun-filled event is being chaired by Shannon Broder, Don McDonough, Lizzie McDonough, John Rigos, Erin Stern, and Andrew Ste...

Aduro Announces Poster Presentations of Phase 2 Pancreatic Cancer and Phase 1B Mesothelioma Clinical Trials at ASCO

Aduro BioTech, Inc. announces two poster presentations at the upcoming American Society of Clinical Oncology (ASCO) annual meeting in Chicago. Dr. Raffit Hassan, Head of the Solid Tumor Immunotherapy Section at the Laboratory of Molecular Biology at the National Cancer Institute, will present data from Aduro’s Phase 1B clinical trial in patients with mal...

Acorda Therapeutics Announces Issuance of Additional U.S. Patent for AMPYRA® Covering a Range of Dosage Strengths

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent Application No. 8,440,703 (“the ‘703 patent”) entitled “Methods of Using Sustained Release Aminopyridine Compositions.” The ‘703 patent includes claims directed to methods of improving lower extremity function and...

Nexus Legal Cash Announces Sponsorship of TVT-NO! Foundation

YONKERS, N.Y., May 20, 2013 /PRNewswire/ -- Nexus Legal Cash, the legal funding company, is delighted to announce a landmark sponsorship of TVTNO.org, a not for profit organization that was created to aid, comfort, advocate and provide awareness to women suffering from complications arising from transvaginal mesh and its use. TVT-NO! Foundation, created by Teresa Sawyer and her husband David...

Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company

PARSIPPANY, N.J. and DUBLIN, May 20, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT) and Warner Chilcott plc (NASDAQ: WCRX) today announced they have entered into a definitive agreement under which Actavis will acquire Warner Chilcott plc in a stock-for-stock transaction valued at approximately $8.5 billion.  If successfully completed, the transaction will create a leading global specialty pha...

Fastcare Advises on How to Prevent a UTI

Miami, FL (PRWEB) May 20, 2013 Fastcare Miami Beach clinic advises patients to treat a possible urinary tract infection (UTI) within its first symptoms, as if not treated, it may involve the ureter and the kidneys resulting in a more serious inf...

Powerful imaging tool unlocks kidneys' secrets

(Medical Xpress)—A powerful new way of imaging kidneys is providing scientists with insights into the importance of the body's filtering system and how it is affected by cardiovascular disease, stroke and other health concerns.

Puerto Rico's Caribbean Imaging and Radiation Therapy Center Orders Elekta's New Versa HD System for Treatment of Cancer Patients

PONCE, Puerto Rico, May 17, 2013 /PRNewswire/ -- Serving a region of 650,000 inhabitants in southern, central and western Puerto Rico, Caribbean Imaging and Radiation Therapy (CIRT, Ponce, PR) Center has improved its radiation therapy capabilities with the acquisition of an Elekta Versa HD™ system, the first in Puerto Rico. Versa HD offers clinicians the versatility to deliver conventio...

How To Find Out Your Genetic Risk Factors Like Angelina Jolie Did

SAN FRANCISCO, May 17, 2013 /PRNewswire/ -- When Angelina Jolie told the world about her double mastectomy, she expressed a wish for all women with a family history of breast cancer: "It is my hope that they, too, will be able to get gene tested, and that if they have a high risk they, too, will know that they have strong options." You may think that such a test is something only movie stars...

Final STRATO Clinical Study Data Demonstrates Potential for LCP-Tacro™ to Improve Tacrolimus-Induced Tremors

HORSHOLM, Denmark, May 20, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that data from the STRATO study demonstrates the potential for LCP-Tacro™ to improve tacrolimus-induced tremors in stable kidney transplant patients.  The study, Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO™ (STRATO) clinical trial, was presented a...

Oncotype DX prostate cancer assay: Additional data

UK-Norwegian Collaboration Aims to Develop a New Living Skin Equivalent Testing Model for Testing Inflammatory Responses

MANCHESTER, UNITED KINGDOM -- (Marketwired) -- 05/20/13 -- Epistem (LSE: EHP), the UK biotechnology and personalized medicine company with expertise in skin biology and delivery of dermatological testing services, and ScandiDerma, a Norwegian company with expertise in developing new dermatological ingredients from biomass, today announced that they aim to develop a new in vitro human living skin...

Older prostate cancer patients should think twice before undergoing treatment

(University of California - Los Angeles Health Sciences) Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer.

IMRT may not be more effective than older radiation techniques after prostatectomy

(University of North Carolina Health Care) Intensity-modulated radiation therapy has become the most commonly used type of radiation in prostate cancer, but research from the University of North Carolina School of Medicine suggests that the therapy m...

2 radiotherapy treatments show similar morbidity, cancer control after prostatectomy

(The JAMA Network Journals) Use of the newer, more expensive intensity-modulated radiotherapy and use of the older conformal radiotherapy after surgical removal of all or part of the prostate gland were associated with similar morbidity and cancer co...

Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation

The Firm is currently evaluating Actos lawsuits on behalf of long-term users of the drug who were diagnosed with bladder cancer. New York, New York (PRWEB) May 19, 2013 Actos lawsuit claims continue to move forward in a federal litigation now underway in U.S. District Court, Western District of Louisiana. According to a Case Management Order dated May 3rd, the Court has modified the litigation�...

Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial

Columbus, OH (PRWEB) May 19, 2013 The Da Vinci robot lawyers at Wright & Schulte LLC continue to follow developments in the nation’s first trial involving a Da Vinci surgical robot lawsuit. The case, underway in Washington State Superior...

Woodlands Urologists Offer Comprehensive Men's Health Seminar May 22

Texas Regional Urology doctors will offer a complimentary program discussing current treatment of low testosterone, erectile dysfunction, and prostate health. The Woodlands, Texas (PRWEB) May 19, 2013 In response to growing awareness and interest in men's health issues, Dr. Drew Dylewski and Dr. Matthew Hogan of Texas Regional Urology will be offering a complimentary Men's Health Seminar...

Dr. Allen’s Device Reverses Prostate Enlargement without Side Effects in Contrast to BPH Laser Surgeries and TURP, Highlights Fine Treatment

BPH treatment with Dr. Allen’s Device terminates prostate enlargement at the capillary level without any side effects. While a new study suggests that laser therapy for BPH is equally safe and effective as the commonly used TURP, both of these surgical procedures frequently cause serious complications, states Fine Treatment. London, UK (PRWEB) May 18, 2013 When selecting a prostate enlargement...

Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team

Courtney Marino, RDH, the Newest Member of Ravera’s Practice, Works With Patients of All Ages to Promote Positive Oral Hygiene Care Newport Beach, CA (PRWEB) May 18, 2013 John Ravera, D.D.S., a Newport Beach cosmetic dentist, has recently announced the addition of a new member to his dental team, Courtney Marino. Marino is a dental hygienist who has worked in the field for over 10 years. She re...

Pharmaceutical Research: Preparation, Drug Release, and Cell Growth Inhibition of a Gelatin: Doxorubicin Conjugate

Type: Original PaperPurposeTo demonstrate the feasibility of a novel macromolecular delivery system for doxorubicin (DOX) which combines pH dependent DOX release with a high molecular weight and biodegradable gelatin carrier.MethodsDOX was conjugated...

Among Patients Carrying BRCA Mutations, PARP Inhibitor Shows Activity In Pancreatic, Prostate Cancers

In the largest clinical trial to date to examine the efficacy of PARP inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced pancreatic and prostate...